(Rochelle Park, NJ; July 26, 2011) - TKL Research announced today that Kevin Vernarec has assumed the newly created position of Vice President of Operational Excellence.
In this new role, Vernarec will carry the responsibility for ensuring that all clinical research organization (CRO) systems and processes are performed with optimum quality and are executed utilizing appropriately allocated resources. Also, he will assure that the best technology is used in the most cost-efficient means possible.
“Those who have worked with Kevin appreciate the deep experience and vast knowledge he has brought to TKL with new or improved ways of delivering our services,” said Dr. Bob Reardon, Executive Vice President, COO. “The objective of his role is to ensure client satisfaction and continuous operational improvements resulting in exceptional and increasing business relationships.”
Prior to TKL Research, Vernarec held a variety of high-level operations positions for multinational CROs. His breadth of experience covers global project management, clinical operations, proposals, budgeting and costing, CTMS and EDC systems implementation, vendor management, process re-engineering and project planning and tracking. Kevin holds a Bachelor of Science degree in biology from Pennsylvania State University.
About TKL Research
Headquartered in Rochelle Park, New Jersey, TKL Research is a full-service international clinical research organization (CRO) serving the pharmaceutical, biotechnology, medical device and consumer healthcare industries. TKL Research provides comprehensive clinical trial management services for Phase I-IV clinical research studies, including an inpatient Phase I facility and outpatient specialized research clinics while delivering to our clients a competitive edge with accelerated enrollment.